Found 5 matching trials
Sodium-glucose Co-transporter 2 Inhibitors Effects in Failing Heart Patients PHASE4 SLGT2 therapy is safety used in heart failure (HF) patients with depressed ...
Show More Location
Raffaele Marfella
Learn More & Join Trial
Study of Dapagliflozin on Mitochondrial Dysfunction and Impaired Insulin Signaling/Action NA The purpose of this study is to examine the effect of the chronic treatment...
Show More Location
Diabetes Division, UTHSCSA
Learn More & Join Trial
EMPA-ESUS. a Randomised Control Trial to Investigate the Impact of Empagliflozin on Left Atrial Function in Patients with Embolic Stroke of Undetermined Source PHASE2 Atrial fibrillation (AF) is the most common heart rhythm problem in the adu...
Show More Location
Addenbrookes Hospital
Learn More & Join Trial
BESTMED: Observational Evaluation of Second Line Therapy Medications in Diabetes N/A An observational study of electronic patient data to compare diabetes medic...
Show More Learn More & Join Trial
The Role of SGLT2i in Management of Moderate AS PHASE2 Background:
The aortic valve is like a door in the heart that lets blood f...
Show More Location
Norfolk and Norwich University Hospital
Learn More & Join Trial